Kiran Mazumdar-Shaw picks niece Claire Mazumdar as successor at Biocon: Report

Claire Mazumdar, 37 years of age, currently heads Bicara Therapeutics as its founder and CEO. The firm, which was incubated by Biocon and later listed on NASDAQ, went public in 2024 and now has a market valuation of over $1.6 billion.

from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/XlsN9Dp
https://ift.tt/emk3DRq